Profil
Carla Fiankan is Vice President-Regulatory at InterMune, Inc. since 2011.
Formerly, Ms. Fiankan was Associate Director-Regulatory Affairs at Gilead Sciences, Inc. from 2003 to 2010 and Vice President-Regulatory Affairs at Adverum Biotechnologies, Inc. Education includes an undergraduate degree from Notre Dame de Namur University in 1990 and a graduate degree from San Jose State University in 1993.
Postes actifs de Carla Fiankan
| Sociétés | Poste | Début |
|---|---|---|
| INTERMUNE INC | Conseiller Juridique Général | 01/08/2011 |
Anciens postes connus de Carla Fiankan
| Sociétés | Poste | Fin |
|---|---|---|
| ADVERUM BIOTECHNOLOGIES, INC. | Conseiller Juridique Général | 09/12/2025 |
| GILEAD SCIENCES, INC. | Conseiller Juridique Général | 01/12/2010 |
Formation de Carla Fiankan
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
InterMune, Inc.
InterMune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Notre Dame de Namur University
Notre Dame de Namur University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
San Jose State University
San Jose State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc. BiotechnologyHealth Technology Operates as a clinical-stage company that develops gene therapies | Health Technology |
















